DEP0011062MA - - Google Patents
Info
- Publication number
- DEP0011062MA DEP0011062MA DEP0011062MA DE P0011062M A DEP0011062M A DE P0011062MA DE P0011062M A DEP0011062M A DE P0011062MA
- Authority
- DE
- Germany
- Prior art keywords
- pectin
- aluminum hydroxide
- adsorbate
- aluminum
- salt solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001277 pectin Polymers 0.000 claims description 14
- 239000001814 pectin Substances 0.000 claims description 14
- 235000010987 pectin Nutrition 0.000 claims description 12
- 239000002156 adsorbate Substances 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- 229960005486 vaccine Drugs 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 5
- 229910052782 aluminium Inorganic materials 0.000 claims description 5
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 238000002649 immunization Methods 0.000 claims description 3
- 230000003053 immunization Effects 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000012266 salt solution Substances 0.000 claims description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 2
- 230000003139 buffering effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 239000003948 anatoxin Substances 0.000 description 2
- 230000001147 anti-toxic effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000240 adjuvant effect Effects 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000008752 local inflammatory process Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Chemical class 0.000 description 1
- 229910052708 sodium Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69528074T2 (de) | Chitosan induzierte verstärkung | |
| DE13837694T1 (de) | Daptomycinformulierungen und Verwendungen davon | |
| DE04007657T1 (de) | Pharmazeutische Zusammensetzung aus fibrinolytischem Mittel | |
| DE3032488A1 (de) | Verfahren zur herstellung eines impfstoffs | |
| CA1290690C (en) | Method of reducing the swelling or pain associated with antibiotics compositions | |
| CH690490C2 (de) | Anthracyclinglycosidlösung. | |
| DE2461439B2 (de) | Verfahren zur Herstellung eines schützenden Antigens von BordeteUa Pertussis sowie jenes enthaltendes Mittel | |
| DE3686158T2 (de) | Impfstoff gegen mastitis. | |
| DE3834729A1 (de) | Verwendung von zink-oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen | |
| DE2409862B2 (de) | Verwendung einer oral applizierbaren Immunoglobulinkombination | |
| DE940062C (de) | Verfahren zur Herstellung von Adsorbatimpfstoffen | |
| DEP0011062MA (enrdf_load_stackoverflow) | ||
| DE2010788A1 (de) | Wasserunlösliche Substanzen mit Antigenwirkung und Verfahren zu ihrer Herstellung | |
| DE2207287A1 (de) | Carboxyaethylgermaniumsesquioxid und seine herstellung und anwendung | |
| EP0445710B1 (de) | Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen | |
| DE102006031175A1 (de) | Wässrige Arzneimittelformulierung von 4-[((4-Carboxybutyl)-(2[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoesäur | |
| DE19940011B4 (de) | Alginataufbereitung und deren Verwendung | |
| DE2825619A1 (de) | Vakzinen gegen ferkel-colibacillose und verfahren zu ihrer herstellung | |
| DE10027050A1 (de) | Alginathaltige Zusammensetzung und deren Verwendung | |
| DE10113284A1 (de) | Adjuvans-Emulsion und Verfahren zu deren Verwendung | |
| CH455146A (de) | Verfahren zur Herstellung von Diphtherie-Toxoiden | |
| AT397756B (de) | Futtermittelzusatz | |
| DD298884A5 (de) | Impfstoffe gegen virale antigene und verfahren zu ihrer herstellung | |
| CH645270A5 (en) | Vaccine against coli bacillosis of piglets and process for its preparation | |
| AT115408B (de) | Verfahren zur Darstellung eines Schutzmittels gegen Diphterie in Form einer in die Haut einreibbaren Masse. |